Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Abstract The novel coronavirus 2019, or COVID-19, infection has rapidly spread through the New York metropolitan area since the first reported case in the state on March 1, 2020. New York currently represents an epicenter for COVID-19 infection in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early experience with seven COVID-positive patients in pregnancy, including two women who were diagnosed with COVID-19 following an asymptomatic initial presentation. We now describe a series of 43 test-confirmed cases of COVID-19 presenting to a pair of affiliated New York City hospitals over two weeks from March 13 to 27, 2020. Fourteen (32.6%) patients presented without any COVID-associated viral symptoms, and were identified either after developing symptoms during admission or following the implementation of universal testing for all obstetrical admissions on March 22. Of these, 10/14 (71.4%) developed symptoms or signs of COVID-19 infection over the course of their delivery admission or early after postpartum discharge. Of the other 29 (67.4%) patients who presented with symptomatic COVID-19 infection, three women ultimately required antenatal admission for viral symptoms, and an additional patient represented six days postpartum after a successful labor induction with worsening respiratory status that required oxygen supplementation. There were no confirmed cases of COVID-19 detected in neonates upon initial testing on the first day of life. Applying COVID-19 disease severity characteristics as described by Wu et al, 37 (86%) women possessed mild disease, four (9.3%) exhibited severe disease, and two (4.7%) developed critical disease; these percentages are similar to those described for non-pregnant adults with COVID-19 infections (about 80% mild, 15% severe, and 5% critical disease).

[1]  K. Kim,et al.  What Is COVID-19? , 2020, Frontiers for Young Minds.

[2]  M. D'Alton,et al.  COVID-19 in pregnancy: early lessons , 2020, American Journal of Obstetrics & Gynecology MFM.

[3]  G. Saccone,et al.  MFM guidance for COVID-19 , 2020, American Journal of Obstetrics & Gynecology MFM.

[4]  M. D'Alton,et al.  Coronavirus disease 2019 in pregnancy: early lessons , 2020, American Journal of Obstetrics & Gynecology MFM.

[5]  M. Biggerstaff,et al.  H1N1 2009 influenza virus infection during pregnancy in the USA , 2009, The Lancet.

[6]  M. Gimovsky,et al.  Two Cases of COVID-19 Related Cardiomyopathy in Pregnancy , 2020 .

[7]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[8]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[9]  A. Khalil,et al.  Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis , 2020, American Journal of Obstetrics & Gynecology MFM.

[10]  Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  T. Manuck,et al.  Extracorporeal membrane oxygenation in pregnant and postpartum women: a ten-year case series , 2020, American Journal of Obstetrics & Gynecology MFM.

[12]  Min Kang,et al.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.

[13]  S. Rasmussen,et al.  Pandemic Influenza and Pregnant Women , 2008, Emerging infectious diseases.

[14]  Russell S. Miller,et al.  COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals , 2020 .

[15]  Huixia Yang,et al.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records , 2020, The Lancet.

[16]  Udita Agrawal,et al.  Improved oral bioavailability of bioactives through lipid-based nanoarchitectures**Declaration of Interest: The authors report no conflict of interest. , 2016 .

[17]  Lingkong Zeng,et al.  Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. , 2020, JAMA pediatrics.

[18]  Lin Yang,et al.  Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study , 2020, medRxiv.

[19]  Jiazheng Wang,et al.  Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. , 2020, AJR. American journal of roentgenology.

[20]  T. Ng,et al.  Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome , 2004, American Journal of Obstetrics and Gynecology.